Every investor in McKesson Corporation (NYSE:MCK) should be aware of the most powerful shareholder groups. With 90% stake, ...

McKesson (MCK) ended the recent trading session at $831.21, demonstrating a +1.08% change from the preceding day's closing ...

Preview this article 1 min Irving-based McKesson, the largest publicly traded company in Dallas-Fort Worth, closed its first deal of the year as it seeks to focus on ramping up its oncology and ...

Why McKesson (MCK) is on investors’ radar today McKesson (MCK) is drawing attention after recent share price moves, with the ...

Morgan Stanley upgraded Cencora (COR) and raised price targets on its rivals, McKesson Corporation (MCK) and Cardinal Health ...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise ...

We recently published 10 Stocks Jim Cramer Talked About. McKesson Corporation (NYSE:MCK) is one of the stocks on Jim Cramer talked about. McKesson Corporation (NYSE:MCK) is one of the largest ...

Ending months of speculation, McKesson opted last month to separate its IT business so that it could focus its resources on its growing drug distribution business. Under a plan outlined last June, ...

McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow, despite recent price increases and solid growth prospects in oncology and GLP-1 medications. Quarterly ...

Healthcare services company McKesson has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures (Core Ventures) for about $2.49 ...

McKesson Corporation MCK has delivered a strong fiscal second quarter, reinforcing confidence in management’s full-year outlook and longer-term strategic repositioning. The company reported ...